Nvision Biomedical Technologies™, San Antonio, Texas (USA) and Invibio Biomaterial Solutions™ (Invibio Ltd, part of Victrex plc, Lancashire, UK), today announce that the U.S. Food and Drug Administration (FDA) has granted clearance of the first 3D-Printed PEEK Interbody System made from PEEK-OPTIMA™, a polymer from Invibio Biomaterial Solutions (‘Invibio’) and using the proprietary Bond3D additive manufacturing technology.
The 3D-Printed PEEK Interbody System from Nvision Biomedical Technologies, a San Antonio-based medical device and implant manufacturer, was co-developed with Invibio Biomaterial Solutions. The system consists of Cervical and Anterior Lumbar Interbody Fusion (ALIF) spine devices, each incorporating extensive porous structures that have the potential to promote multi-directional bone ingrowth and improve device fixation, whilst also maintaining PEEK-OPTIMA’s inherent benefits in modulus and imaging.
The use of PEEK-OPTIMA™ - a material that has already been used in over 15 million implants - offers the benefits of mechanical properties closer to those of bone and also superior imaging capability than titanium implants, the latter allowing surgeons to more accurately monitor fusion progression. Nvision’s 3D-Printed PEEK Interbody System is a standout in the field of spinal devices as it is the first to combine PEEK-OPTIMA with the design freedom enabled by the Bond3D additive manufacturing technology to print solid and porous areas for bone ingrowth.
Brian Kieser, CEO of Nvision Biomedical Technologies, commented “Our partnership with Invibio on this project showcases our commitment to pushing the boundaries of medical device innovation”. Kieser continued “This latest FDA clearance builds on a history of successful co-development between Nvision and Invibio, particularly in spine and foot-and-ankle devices. We are thrilled to introduce the 3D-Printed PEEK Cervical and ALIF lines, available in various footprints and lordotic angles, and all incorporating the same porous design features aimed at promoting bone ingrowth.”
Tom Zink, Senior Vice President of Product Development at Nvision Biomedical Technologies, added “We’re constantly looking at new ways to equip surgeons with the opportunity to get the best outcomes for their patients. Leveraging this cutting-edge PEEK additive manufacturing platform through Invibio enables us to take a more innovative approach in the design process and address previous limitations.”
Dr. Steven Lee, MD a spine and orthopedic surgeon gave a clinical end-user perspective, stating - “These new interbody devices, conceived from the collaboration of Nvision and Invibio, will allow me to further improve the quality of care and surgical outcomes that I can provide to my patients. PEEK-OPTIMA’s modulus of elasticity helps to prevent subsidence. Its radiolucency allows for the confirmation of the fusion process. The benefit of a printed porous structure that mimics native bone allows for bone growth into the device itself - thereby enhancing the construct stability. These combined new implant characteristics of strength, reduced subsidence, boney ingrowth, and radiolucency will provide clinical benefits to all my patients.”
Nvision and Invibio collaborated in the development of the 3D-printed PEEK Interbody System, with Invibio carrying out development of the PEEK-OPTIMA and Bond3D technology platform, performance testing early in the process, and eventually filing a new master file (MAF) with the FDA to support this and future regulatory submissions.
John Devine, MD of Invibio said “The proprietary BOND3D advanced manufacturing process used in this device is available through Invibio to allow device companies to realise their innovative designs. Being able to access this process is a breakthrough for device companies because it allows much greater design freedom that would not otherwise be possible with conventional manufacturing methods”. Devine continued, “The combination of solid and highly intricate porous PEEK-OPTIMA structures within the Nvision system allows for potential bone ingrowth to achieve fixation while maintaining the inherent benefits of PEEK-OPTIMA for imaging and bone-like modulus.”
Nvision and Invibio remain committed to continuous innovation in the medical device field, with future focus aimed at expanding the applications of 3D printed PEEK technology to meet the growing needs of surgeons and patients worldwide.
About Nvision Biomedical Technologies
Nvision is a San Antonio-based medical device and implant manufacturer focused on providing surgeons with implants paired with instrumentation and biologics that simplify and improve surgery procedures to help patients get back to their quality of life. Nvision is committed to developing and manufacturing thoughtfully designed products combined with exceptional service that keep the patient, surgeons, healthcare providers, and distribution partners in mind. Nvision is aligned with surgeon thought leaders, key researchers, and development engineers from prestigious institutions to design, test, and bring to market the most innovative concepts. Find out more at www.nvisionbiomed.com
About Invibio Biomaterial Solutions
Invibio, part of the Victrex plc group of companies, is a global leader in providing high-performance biomaterial solutions to medical device manufacturers. The company provides PEEK-OPTIMA™ polymers, advanced technical research and support and manufacturing of components for spine, trauma and orthopaedic medical segments for the development of long-term implantable medical devices. Today, Invibio’s PEEK-OPTIMA polymers are used in approximately 15 million implanted devices worldwide. Learn more at www.invibio.com
About Victrex plc
Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of automotive, aerospace, energy & industrial, electronics and medical. Every day, millions of people use products and applications which contain our sustainable materials – from smartphones, aeroplanes and cars to energy production and medical devices. With over 40 years’ experience, we develop world leading solutions in PEEK and PAEK based polymers, semi-finished and finished parts which shape future performance for our customers and our markets, enable environmental and societal benefits, and drive value for our shareholders. Find out more at www.victrex.com
Nvision Biomedical Technologies media contact
Bonnie Caver, bonnie@replighthouse.com, Phone 512-217-5397
Victrex plc.
Melanie Embery, Head of Marketing Communications membery@victrex.com,
Group media or Investor Relations enquiries
Andrew Hanson, Director of Investor Relations, Corporate Communications and ESG ahanson@victrex.com